Ralph W Niven

Title: Ralph W. Niven: Innovator in Nucleic Acid Delivery

Introduction

Ralph W. Niven is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid delivery systems. His innovative work has the potential to impact cancer treatment and gene therapy.

Latest Patents

Ralph W. Niven holds a patent for a "Cationic lipid formulation delivering nucleic acid to peritoneal tumors." This patent outlines methods of transfecting cells in vivo, including tumor cells located in the peritoneal cavity. The formulation provides related lipid:nucleic acid combinations that are specifically designed for effective transfection of cells in this challenging environment. Additionally, the patent includes assays, such as high-throughput assays, for screening lipid:nucleic acid formulations.

Career Highlights

Ralph W. Niven is associated with Valentis, Inc., a company focused on advancing gene therapy technologies. His work at Valentis has allowed him to explore innovative solutions for delivering therapeutic agents to targeted areas within the body.

Collaborations

Throughout his career, Ralph has collaborated with esteemed colleagues, including Janet G. Smith and Yilin Zhang. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge biotechnological solutions.

Conclusion

Ralph W. Niven's contributions to the field of nucleic acid delivery exemplify the importance of innovation in biotechnology. His work continues to pave the way for advancements in cancer treatment and gene therapy.